Hydrocodone/guaifenesin

Last updated

Hydrocodone/guaifenesin
Combination of
Hydrocodone Opioid agonist
Guaifenesin Expectorant
Clinical data
Trade names Obredon, Flowtuss, others
AHFS/Drugs.com
License data
Routes of
administration 		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Hydrocodone/guaifenesin, sold under the brand name Obredon among others, is a fixed-dose combination medication used for the treatment of cough. [2] It contains hydrocodone, as the bitartrate, an opioid agonist; and guaifenesin, an expectorant. [2] It is taken by mouth. [2]

Hydrocodone/guaifenesin was approved for medical use in the United States in 2014. [3] [4]

Adverse effects

In the US, the label for hydrocodone/guaifenesin contains a black box warning about addiction, abuse, and misuse. [2]

References

  1. ↑ "Flowtuss (hydrocodone bitartrate and guaifenesin) oral solution, CII Initial U.S. Approval: 2014". DailyMed. Retrieved 21 December 2023.
  2. 1 2 3 4 5 "Obredon- hydrocodone bitartrate and guaifenesin solution". DailyMed. 15 December 2023. Retrieved 21 December 2023.
  3. ↑ "Flowtuss, (hydrocodone bitartrate and guaifenesin), oral solution". U.S. Food and Drug Administration (FDA). 29 February 2016. Archived from the original on 21 October 2020. Retrieved 21 December 2023.
  4. ↑ "Obredon, (hydrocodone/guaifenesin) Oral Solution". U.S. Food and Drug Administration (FDA). 7 April 2015. Retrieved 21 December 2023.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.